Estudio de fase 3, aleatorizado, doble ciego y controlado con placebo para evaluar la eficacia y la seguridad de upadacitinib en sujetos adultos y adolescentes con con hidradenitis supurativa moderada o grave que no han respondido al tratamiento anti-TNF”.

Dades bàsiques

Protocol:
M23-698
EURDRACT:
2023-503661-28-00
NCT:
Centre:
HOSPITAL UNIVERSITARI I POLITÈCNIC LA FE
Any inici:
2023
Any de finalització:
ENSAYO CLÍNICO

Documents

  • No hi ha documents

Participants

Grups d'Investigació

Finançadors - Promotors

ABBVIE DEUTSCHLAND GMBH & CO. KG

Resultats de l'Assaig Clínic


[[Translated article]]Drug Survival in Cyclosporine Treatment for Moderate to Severe Atopic Dermatitis: Analysis of the Spanish Atopic Dermatitis Registry (BIOBADATOP).

Couselo-Rodríguez C; (...); Flórez Á

Article. 10.1016/j.ad.2023.07.028. 2024

  • Open Access.

[[Translated article]]Requirements for Accessing New Dermatology Drugs in Spain: Results of the EQUIDAD Study.

Sanchez-Diaz, M; (...); Carrascosa-Carrillo, J M

Article. 10.1016/j.ad.2024.01.019. 2024

  • Open Access.

[Translated article] BIOBADATOP Spanish Atopic Dermatitis Registry: Description and Early Findings.

Munera-Campos M; (...); Carrascosa JM

Article. 10.1016/j.ad.2023.05.010. 2023

  • Open Access.

[Translated article] Fatal outcome in classic Kaposi's sarcoma.

Mansilla-Polo M, Botella-Estrada R

Article. 10.1016/j.ad.2024.03.015. 2024

  • Open Access.

[Translated article] Knowledge of biological therapy in patients with immune-mediated diseases. BIOINFO study.

Segui-Solanes, Carlos; (...); Borras-Blasco, Joaquin

Article. 10.1016/j.farma.2024.08.002. 2024

  • Open Access.

[Translated article] New challenges in advanced therapies.

Megías-Vericat JE; (...); Poveda Andrés JL

Article. 10.1016/j.farma.2024.05.001. 2024

  • Open Access.

[Translated article] Pharmacokinetic-guided switching from standard half-life factor VIII to extended half-life pegylated factor VIII in haemophilia A therapy in clinical practice.

Chovi-Trull, Maria; (...); Andres, Jose Luis Poveda

Article. 10.1016/j.farma.2024.12.007. 2025


A Case of Localised Immediate Hypersensitivity Reaction to Bimekizumab.

Lasheras-Perez, Miguel Antonio; (...); Ibanez-Echevarria, Ethel

Article. 10.1111/cod.14774. 2025


A Gadolinium(III) Complex Based on Pyridoxine Molecule with Single-Ion Magnet and Magnetic Resonance Imaging Properties.

Orts-Arroyo, Marta; (...); Martinez-Lillo, Jose

Article. 10.3390/ijms25042112. 2024

  • Open Access.

A Non-Interventional, Multicenter Study to Characterize the Socio-Demographics, Clinical Characteristics, and Management of Generalized Pustular Psoriasis Patients in Spain: IMPULSE Study

Puig, Lluis; (...); IMPULSE Investigators Grp

Article. 10.1159/000540019. 2024

  • Open Access.

Ability of antigen carbohydrate 125 for diagnosis of heart failure with preserved ejection fraction

De Juan Baguda, J. Javier; (...); Delgado Jimenez, J. F.

Meeting Abstract. 2024


Acute performance of stylet driven leads for left bundle branch area pacing: A comparison with lumenless leads

Cano, Oscar; (...); Batul, Syeda Atiqa

Article. 10.1016/j.hroo.2023.11.014. 2023

  • Open Access.

Alterations in Mitochondrial Oxidative Phosphorylation System: Relationship of Complex V and Cardiac Dysfunction in Human Heart Failure

Gimenez-Escamilla, Isaac; (...); Rosello-Lleti, Esther

Article. 10.3390/antiox13030285. 2024

  • Open Access.

Altered MicroRNA Maturation in Ischemic Hearts: Implication of Hypoxia on XPO5 and DICER1 Dysregulation and RedoximiR State.

Perez-Carrillo, Lorena; (...); Rosello-Lleti, Esther

Article. 10.3390/antiox12071337. 2023

  • Open Access.

Analysis of complications in patients with ECMO as a bridge to transplantation since the beginning of the technique (2007-2023)

Guerrero Cervera, Borja; (...); Almenar Bonet, Luis

Meeting Abstract. 2024


Annual evolution of the prescription of drugs with prognostic implications in acute decompensated heart failure with reduced ejection fraction.

López-Vilella R; (...); Almenar Bonet L

Article. 10.1186/s12872-024-03728-y. 2024

  • Open Access.

Benefits of physical activity self-monitoring in patients with haemophilia: a prospective study with one-year follow-up.

Pérez-Alenda S; (...); Núñez-Cortés R

Article. 10.1111/hae.14988. 2024

  • Open Access.

CA125: a new biomarker in patients with Fontan circulation (vol 76, pg 112, 2023)

Fuentes, Francisco Buendia; (...); Soriano, Joaquin Rueda

Correction. 10.1016/j.rec.2023.03.018. 2023


Casal necklace.

Mansilla-Polo, Miguel, Martin-Torregrosa, Daniel, Botella-Estrada, Rafael

Article. 10.1016/j.medcli.2023.03.035. 2023


Certolizumab pegol effectiveness, survival and safety in patients with psoriasis: A multicenter retrospective analysis in daily clinical practice by the Spanish Psoriasis Group

Sahuquillo-Torralba, Antonio; (...); Gallardo, Fernando

Article. 10.1111/ijd.17238. 2024


Circulating long non-coding RNAs detection after heart transplantation and its accuracy in the diagnosis of acute cardiac rejection.

Pérez-Carrillo L; (...); Roselló-Lletí E

Letter. 10.1186/s40364-024-00590-0. 2024

  • Open Access.

Clinical profiling of patients admitted with acute heart failure: a comprehensive survival analysis.

Lopez-Vilella, Raquel; (...); Almenar Bonet, Luis

Article. 10.3389/fcvm.2024.1381514. 2024

  • Open Access.

Clinical, echocardiographic and analytical patterns of biomarkers in cardiac amyloidosis; a real-world analysis.

Lopez Vilella, R. Raquel; (...); Almenar Bonet, L.

Meeting Abstract. 2024


Combining Serum miR-144-3p and miR-652-3p as Potential Biomarkers for the Early Diagnosis and Stratification of Acute Cellular Rejection in Heart Transplantation Patients.

Pérez-Carrillo L; (...); Roselló-Lletí E

Article. 10.1097/TP.0000000000004622. 2023

  • Open Access.

Comparative Temporal Analysis of Morbidity and Early Mortality in Heart Transplantation with Extracorporeal Membrane Oxygenation Support: Exploring Trends over Time

Lopez-Vilella, Raquel; (...); Bonet, Luis Almenar

Article. 10.3390/biomedicines12092109. 2024

  • Open Access.

Comprehensive survival analysis in acute heart failure: profiling patients through clinical examination at admission

Raquel Lopez Vilella, R.; (...); Almenar Bonet, L.

Meeting Abstract. 2024


Conduction System Pacing for Cardiac Resynchronization Therapy

Cano, Oscar; (...); Martinez-Dolz, Luis

Review. 10.3390/jcdd10110448. 2023

  • Open Access.

Correction: 'Lesion on the back of the hand in a hematopoietic stem cell transplant recipient'.

Mansilla-Polo M; (...); Botella-Estrada R

Correction. 10.1007/s15010-024-02259-0. 2024

  • Open Access.

Cost-effectiveness and cost-utility analysis of haemate-P versus other von willebrand disease treatments in Spain.

Megias-Vericat, Juan E; (...); Yan, Songkai

Article. 10.1080/13696998.2025.2474886. 2025


Culprit-Lesion Drug-Coated-Balloon Percutaneous Coronary Intervention in Patients Presenting with ST-Elevation Myocardial Infarction (STEMI)

Sanz-Sanchez, Jorge; (...); Santos, Ignacio Amat

Article. 10.3390/jcm14030869. 2025

  • Open Access.

Cutaneous larva migrans.

Mansilla-Polo, Miguel; (...); Botella-Estrada, Rafael

Article. 10.1016/j.medcli.2023.03.037. 2023

  • Open Access.

Cutaneous sarcoidosis after platelet-rich plasma injections and permanent eyebrow make-up.

Torregrosa DM; (...); Estrada RB

Case Reports. 10.1016/j.ad.2023.06.023. 2024

  • Open Access.

Chikungunya fever with a positive tourniquet test: a novel description.

Mansilla-Polo M; (...); Botella-Estrada R

Article. 10.1093/ced/llae089. 2024


Delusional parasitosis (Ekbom's syndrome).

Mansilla-Polo, M, Martin-Torregrosa, D, Botella-Estrada, R

Article. 10.1016/j.semerg.2024.102423. 2024

  • Open Access.

Dermatologic Consultations for Patients Hospitalized in Non-Dermatologic Wards: Results of a 384-Patient Cross-Sectional Study From a Tertiary Referral Hospital

Mansilla-Polo, M.; (...); Botella-Estrada, R.

Letter. 10.1016/j.ad.2024.10.030. 2024

  • Open Access.

Dermatologic consultations for patients hospitalized in non-dermatologic wards: results of a 384-patient cross-sectional study from a tertiary referral hospital.

Mansilla-Polo, M; (...); Botella-Estrada, R

Case Reports. 10.1016/j.ad.2023.11.021. 2023


Dermatological toxicities of talquetamab, a new bispecific antibody: case series and literature review.

Mansilla-Polo M; (...); Botella-Estrada R

Letter. 10.1111/ddg.15502. 2024


Dermatological toxicities of talquetamab, a new bispecificantibody: case series and literature review

Mansilla-Polo, Miguel; (...); Botella-Estrada, Rafael

Letter. 10.1111/ddg.15502_g. 2024


Development and testing of a mobile app for systematic collection of patient-reported outcomes (PROs) in patients with hemophilia.

Megias-Vericat, J E; (...); Poveda Andres, J L

Letter. 10.1016/j.thromres.2024.109122. 2024


Does fractional flow reserve impact on clinical outcomes by reducing number of stents and contrast media? Findings from a systematic review (N = 56,185) and meta-analysis.

Teira Calderón A; (...); Garcia-Garcia HM

Letter. 10.1016/j.carrev.2023.12.010. 2024

  • Open Access.

Does Fractional Flow Reserve Impact on Clinical Outcomes? Findings From a Systematic Review (n=56,185) and Meta-Analysis

Teira Calderon, A.; (...); Garcia-Garcia, H. M.

Meeting Abstract. 2024

  • Open Access.

Dose reduction is a feasible strategy in patients with plaque psoriasis who achieve sustained response with secukinumab: a retrospective, multicenter cohort study in daily practice setting

Daudén E; (...); Llamas-Velasco M

Article. 10.1111/ijd.16915. 2024

  • Open Access.

Dose tapering of dupilumab in patients with persistently controlled atopic dermatitis: a Spanish multicenter cohort study

Lasheras-Pérez MA; (...); Rodríguez-Serna M

Article. 10.1111/ijd.17030. 2024

  • Open Access.

Drug survival and safety of biosimilars and originator adalimumab in the treatment of psoriasis: a multinational cohort study.

Phan, Duc Binh; (...); Yiu ZZN

Article. 10.1136/bmjopen-2023-075197. 2023

  • Open Access.

Drug Survival and Safety of Biosimilars Compared with Originator Adalimumab for Psoriasis: A Multinational Cohort Study

Duc Binh Phan; (...); Yiu, Zenas Zee Ngai

Meeting Abstract. 2024


Drug Survival and Safety of Biosimilars Compared with Originator Adalimumab for Psoriasis: A Multinational Cohort Study.

Phan, Duc Binh; (...); Yiu, Zenas Z N

Article. 10.1093/bjd/ljae454. 2024

  • Open Access.

Drug Survival in Cyclosporine Treatment for Moderate to Severe Atopic Dermatitis: Analysis of the Spanish Atopic Dermatitis Registry (BIOBADATOP).

Rodriguez, C Couselo; (...); Florez, A.

Article. 10.1016/j.ad.2023.07.014. 2023

  • Open Access.

Dynamics and prognostic role of persistent angina in chronic coronary syndrome with clinical, angiographic and stress CMR evidence of ischemia

Merenciano-Gonzalez, H.; (...); Bodi, V

Meeting Abstract. 10.1093/eurheartj/ehae666.1329. 2024

  • Open Access.

Effectiveness and safety of brodalumab in the treatment of plaque, scalp and palmoplantar psoriasis: A multicentre retrospective study in a Spanish population.

Sahuquillo-Torralba, A; (...); Botella-Estrada, R

Article. 10.1111/ajd.14130. 2023


Effectiveness of Secukinumab for the treatment of erythrodermic psoriasis. Multicenter study in daily practice.

Reymundo, A; (...); Dauden, E

Letter. 10.1111/jdv.19371. 2023


Effectiveness, safety and satisfaction of 1% tirbanibulin ointment in the treatment of actinic keratoses: A prospective study in real clinical practice.

Mansilla-Polo M; (...); Botella-Estrada R

Letter. 10.1111/ajd.14151. 2023


Efficacy of Risankizumab in Patients with Suboptimal Response or Failure to Ustekinumab: A Multicenter Retrospective Study in Spain

Magdaleno-Tapial, Jorge; (...); Martorell-Calatayud, Antonio

Article. 10.1155/2024/5528484. 2024

  • Open Access.

Endothelial Biomarkers Are Superior to Classic Inflammatory Biomarkers in Community-Acquired Pneumonia.

González-Jiménez P; (...); Méndez R

Article. 10.3390/biomedicines12102413. 2024

  • Open Access.

Erythema Elevatum Diutinum.

Mansilla-Polo M, Botella-Estrada R

Article. 10.1016/j.ad.2023.10.042. 2024

  • Open Access.

Fatal outcome in classic Kaposi's sarcoma.

Mansilla-Polo M, Botella-Estrada R

Article. 10.1016/j.ad.2023.03.013. 2024

  • Open Access.

Genetic polymorphisms to identify patients with an optimal response to tildrakizumab in psoriasis patients from real-life clinical practice.

Butrón-Bris B; (...); de la Fuente H

Article. 10.1111/exd.15152. 2024

  • Open Access.

Guselkumab, Risankizumab, and Tildrakizumab demonstrate parallel effectiveness and safety in psoriasis treatment: a head-to-head comparative study in real clinical practice.

Mansilla-Polo M; (...); Botella-Estrada R

Article. 10.1016/j.abd.2024.04.004. 2024

  • Open Access.

Histological deep margins in cutaneous squamous cell carcinoma of the scalp and risk of recurrence.

Verdaguer-Faja, Julia; (...); Jaka, Ane

Article. 10.1111/jdv.20250. 2024

  • Open Access.

Identification of c.104T>G, p.Met35Arg (NM_00314.8) variant in heterozygosity in exon 2 of the PTEN gene as the Causative Factor for Cowden Syndrome: A Medical Case Study.

Mansilla-Polo, Miguel; (...); Botella-Estrada, Rafael

Article. 10.1093/ced/llad344. 2023


Impact of Advanced Age on the Incidence of Major Adverse Cardiovascular Events in Patients with Type 2 Diabetes Mellitus and Stable Coronary Artery Disease in a Real-World Setting in Spain.

González-Juanatey C; (...); Savana Research Group

Article. 10.3390/jcm12165218. 2023

  • Open Access.

Impact on Survival of Heart and Heart-Lung Transplantation in Patients With Cyanotic and Noncyanotic Congenital Heart Diseases.

Donoso-Trenado, Victor; (...); Almenar-bonet, Luis

Article. 10.1016/j.transproceed.2024.12.005. 2024


Initial and Residual Cardiovascular Damage Remaining at Day 30 in Community-acquired Pneumonia

Ocana, R. Mendez; (...); Menendez, R.

Meeting Abstract. https://doi.org/10.1164/ajrccm-conference.2024.209.1_MeetingAbstracts.A6241. 2024

  • Open Access.

Interim analysis of the multinational, post-authorization safety study (NISSO) to assess the long-term safety of sonidegib in patients with locally advanced basal cell carcinoma

Gutzmer, Ralf; (...); Hauschild, Axel

Article. 10.1186/s12885-024-13101-z. 2024

  • Open Access.

Interparietal nodule in a 49-year-old woman.

Mansilla-Polo, Miguel; (...); Botella-Estrada, Rafael

Case Reports. 10.1111/ddg.15398. 2024


Interparietaler Knoten bei einer 49-jährigen Frau

Mansilla-Polo, Miguel; (...); Botella-Estrada, Rafael

Article. 10.1111/ddg.15398_g. 2024


Klinisch-pathologische Eigenschaften kutaner und mukokutaner Leishmaniose bei mit TNF-a-Inhibitoren behandelten Patienten.

Palacios-Diaz, Rodolfo David; (...); Botella-Estrada, Rafael

Article. 10.1111/ddg.15007_g. 2023

  • Open Access.

Left bundle branch pacing versus left ventricular septal pacing as a primary procedural endpoint during left bundle branch area pacing: Evaluation of two different implant strategies.

Cano, Oscar; (...); Martinez-Dolz, Luis

Article. 10.1111/jce.16128. 2023


'Lesion on the back of the hand in a hematopoietic stem cell transplant recipient'.

Mansilla-Polo M; (...); Botella-Estrada R

Article. 10.1007/s15010-024-02214-z. 2024


Melanoma and LEOPARD Syndrome: Understanding the Role of PTPN11 Mutations in Melanomagenesis.

Palacios-Diaz, Rodolfo David; (...); Botella-Estrada, Rafael

Article. 10.2340/actadv.v104.14720. 2024

  • Open Access.

Mental, emotional and social dimensions of quality of life and their relationship with physical and functional status in adults with haemophilia.

Rodríguez MA; (...); Chimeno-Hernández A

Article. 10.1016/j.thromres.2024.109181. 2024

  • Open Access.

Mohs micrographic surgery in immunosuppressed vs immunocompetent patients: Results of a prospective nationwide cohort study (REGESMOHS, Spanish registry of Mohs surgery).

Abril-Pérez C; (...); Botella-Estrada R

Article. 10.1111/jdv.20103. 2024

  • Open Access.

Mortality after the first hospital admission for acute heart failure de novo vs. acutely decompensated heart failure with reduced ejection fraction

Lopez Vilella, R. Raquel; (...); Almenar Bonet, L.

Meeting Abstract. 2023


Narrative Review and Update on Biologic and Small Molecule Drugs for Hidradenitis Suppurativa: An Entity With a Promising Future.

Mansilla-Polo M, Escutia-Muñoz B, Botella-Estrada R

Article. 10.1016/j.ad.2023.08.001. 2023

  • Open Access.

Narrative Review and Update on Biologic and Small Molecule Drugs for Hidradenitis Suppurativa: An Entity With a Promising Future.

Mansilla-Polo, M., Escutia-Munoz, B., Botella-Estrada, R.

Article. 10.1016/j.ad.2023.05.015. 2023

  • Open Access.

New challenges of advanced therapies.

Megías-Vericat JE; (...); Poveda Andrés JL

Article. 10.1016/j.farma.2023.11.008. 2024

  • Open Access.

Nodular hidradenoma: Case report and brief literature review.

Mansilla-Polo, Miguel; (...); Botella-Estrada, Rafael

Article. 10.1016/j.patol.2025.100801. 2025


Novel Fibrillar and Non-Fibrillar Collagens Involved in Fibrotic Scar Formation after Myocardial Infarction

Ortega, Maria; (...); Ruiz-Sauri, Amparo

Article. 10.3390/ijms25126625. 2024

  • Open Access.

One Dose Risankizumab Effectiveness in Psoriasis: A Real-Life Multicentre Study

Magdaleno-Tapial, Jorge; (...); Sanchez-Carazo, Jose Luis

Article. 10.1155/2024/4866592. 2024

  • Open Access.

Oral Ruxolitinib could Increase the Aggressiveness of Cutaneous Squamous Cell Carcinomas: A 6-Patient Series

Lasheras-Perez, M. A.; (...); Botella-Estrada, R.

Letter. 10.1016/j.ad.2023.07.035. 2025


Papulonecrotic tuberculides as a key to the diagnosis of tuberculosis: a case report.

Mansilla-Polo M; (...); Botella-Estrada R

Letter. 10.1111/ijd.16940. 2024


Paraoxonase I Activity and Its Relationship with Nutrition in Amyotrophic Lateral Sclerosis.

Proaño B; (...); de la Rubia Ortí JE

Article. 10.3390/antiox13081021. 2024

  • Open Access.

Penetrance of Dilated Cardiomyopathy in Genotype-Positive Relatives.

Cabrera-Romero E; (...); Garcia-Pavia P

Article. 10.1016/j.jacc.2024.02.036. 2024

  • Open Access.

Pharmacogenetic biomarkers for secukinumab response in psoriasis patients in real-life clinical practice.

Munoz-Aceituno, E.; (...); de la Fuente, H.

Article. 10.1111/jdv.19782. 2023


Pharmacogenetics in Response to Biological Agents in Inflammatory Bowel Disease: A Systematic Review.

Ballesta-Lopez, Octavio; (...); Poveda-Andres, Jose Luis

Article. 10.3390/ijms26041760. 2025

  • Open Access.

Pharmacological Considerations during Percutaneous Treatment of Heart Failure.

Sorolla-Romero JA; (...); Sanz-Sanchez j

Article. 10.2174/0113816128284131240209113009. 2024


Plaque modification and impact on the microcirculation territory after drug-coated balloon angioplasty. The PLAMI study design

Romero, Jose Antonio Sorolla; (...); Sanchez, Jorge Sanz

Article. 10.24875/RECIC.M23000438. 2024

  • Open Access.

Plasma fibroblast activation protein is decreased in acute heart failure despite cardiac tissue upregulation

Delgado-Arija, Marta; (...); Rosello-Lleti, Esther

Article. 10.1186/s12967-024-04900-w. 2024

  • Open Access.

Podoconiosis.

Mansilla-Polo, Miguel, Lopez-Leon, Paula Teresa, Botella-Estrada, Rafael

Article. 10.1001/jamadermatol.2023.4143. 2023


Practical Requirements for the Development of an Advanced Cardiorenal Unit

Almenar-Bonet, Luis; (...); Sanchez-Perez, Pilar

Review. 10.1159/000536104. 2024

  • Open Access.

Prognostic role of persistent angina after percutaneous revascularization in chronic coronary syndrome with altered angiography and stress CMR.

Perez-Sole, Nerea; (...); Bodi, Vicente

Article. 10.1016/j.rec.2024.09.004. 2024

  • Open Access.

Pulmonary arterial hypertension associated with pretricuspid shunts: risk profile and survival.

Calvo-Asensio, Maria; (...); Rueda Soriano, Joaquin

Article. 10.1016/j.rec.2024.04.016. 2024

  • Open Access.

Raccoon eyes as a diagnostic key for suspected amyloidosis

Mansilla-Polo, Miguel, Botella-Estrada, Rafael

Editorial Material. 10.1093/rap/rkad105. 2023

  • Open Access.

Rationale and study design for an Individualized PeriopeRative Open lung VEntilatory approach in Emergency Abdominal Laparotomy/scopy: study protocol for a prospective international randomized controlled trial.

Laguna G; (...); Ferrando C

Article. 10.1016/j.redare.2024.04.007. 2024


Reactive arthritis.

Mansilla-Polo M; (...); Botella-Estrada R

Article. 10.1016/j.medcli.2023.08.017. 2023


Real-world effectiveness and safety of bimekizumab for hidradenitis suppurativa: An ambispective observational study.

Mansilla-Polo, Miguel; (...); Botella-Estrada, Rafael

Article. 10.1111/ajd.14339. 2024

  • Open Access.

Real-world Safety and Efficacy of Risankizumab in Psoriatic Patients: A Multicenter, Retrospective, and Not-interventional Study.

Martorell A; (...); Magdaleno-Tapial J

Article. 10.1016/j.ad.2024.10.042. 2024


Recalcitrant Hailey-Hailey Disease With Satisfactory Response to Apremilast

Mansilla-Polo, M.; (...); Botella-Estrada, R.

Letter. 10.1016/j.ad.2024.10.025. 2024

  • Open Access.

Recalcitrant Hailey-Hailey Disease With Satisfactory Response to Apremilast.

Mansilla-Polo, M; (...); Botella-Estrada, R

Case Reports. 10.1016/j.ad.2023.05.022. 2023


Recalcitrant lichen planopilaris treated with upadacitinib: a case series

Lasheras-Perez, Miguel A.; (...); Botella-Estrada, Rafael

Article. 10.1111/ijd.17339. 2024


Refractory cutaneous lupus erythematosus successfully treated with anifrolumab: a case series.

Martin-Torregrosa, Daniel; (...); Torres-Navarro, Ignacio

Letter. 10.1111/ijd.17022. 2024


Requirements for Accessing New Dermatology Drugs in Spain: Results of the EQUIDAD Study.

Sanchez-Diaz, M.; (...); Carrascosa-Carrillo, J. M.

Article. 10.1016/j.ad.2023.10.016. 2023

  • Open Access.

Ruxolitinib for foreign body reaction to silicone in a patient with chronic graft-versus-host disease.

Palacios-Diaz, Rodolfo David; (...); Botella-Estrada, Rafael

Letter. 10.1111/ijd.17365. 2024

  • Open Access.

Ruxolitinib oral puede aumentar la agresividad de los carcinomas escamosos cutáneos: serie de 6 pacientes.

Lasheras-Perez MA; (...); Botella-Estrada R

Article. 10.1016/j.ad.2024.10.003. 2025


Safety of biologic therapy in combination with methotrexate in moderate to severe psoriasis: a cohort study from the BIOBADADERM registry.

Lluch-Galcera, Juan Jose; (...); Garcia-Doval, Ignacio

Article. 10.1093/bjd/ljad382. 2023


Safety of biosimilars compared with originator adalimumab for psoriasis: a multinational cohort study

Phan, Duc Binh; (...); Yiu, Zenas

Meeting Abstract. 10.1093/bjd/ljae360.068. 2024

  • Open Access.

Sarcoidosis cutánea tras inyecciones de plasma rico en plaquetas y maquillaje permanente de cejas.

Martín-Torregrosa D; (...); Botella-Estrada R

Article. 10.1016/j.ad.2024.10.043. 2024

  • Open Access.

Scaling and periorificial crusts in a pediatric patient.

Fayos-Gregori, Rafael; (...); Botella-Estrada, Rafael

Article. 10.1007/s15010-024-02309-7. 2024


Scalp Melanoma: A High-Risk Subset of Cutaneous Head and Neck Melanomas with Distinctive Clinicopathological Features.

Palacios-Diaz RD; (...); Botella-Estrada R

Article. 10.3390/jcm12247643. 2023

  • Open Access.

Sex and clinical outcomes in new-onset heart failure.

Vicent, Lourdes; (...); Martinez-Selles, Manuel

Article. 10.1016/j.ijcard.2025.133092. 2025


Single Digital Metastasis of Rectal Adenocarcinoma

Mansilla-Polo, Miguel; (...); Botella-Estrada, Rafael

Letter. 10.1097/DAD.0000000000002529. 2023

  • Open Access.

Skin cancer risk after hematopoietic stem cell transplantation: a systematic review and meta-analysis.

Mansilla-Polo M; (...); Botella-Estrada R

Article. 10.1111/ijd.17371. 2024


Skin lesions in a lung transplant recipient

Mansilla-Polo, Miguel; (...); Botella-Estrada, Rafael

Editorial Material. 10.1016/j.eimc.2023.09.005. 2024

  • Open Access.

Skin lesions in a lung transplant recipient.

Mansilla-Polo M; (...); Botella-Estrada R

Case Reports. 10.1016/j.eimce.2023.09.005. 2024

  • Open Access.

Slowed-down temporal vein refilling as diagnostic pearl in frontal fibrosing alopecia.

Mansilla-Polo, Miguel, Martin-Torregrosa, Daniel, Torres-Navarro, Ignacio

Article. 10.1016/j.jaad.2024.06.062. 2024


Study of Microsatellite Instability by Immunohistochemistry in a Cohort of Patients With Melanoma

Diaz, Rodolfo David Palacios; (...); Estrada, Rafael Botella

Article. 10.1111/cup.14758. 2025


Successful treatment of erythema nodosum leprosum with upadacitinib and roflumilast.

Mansilla-Polo, Miguel; (...); Torres-Navarro, Ignacio

Letter. 10.1111/ijd.17293. 2024

  • Open Access.

Successful treatment of field of cancerization in the dorsum of the hands with 1% tirbanibulin ointment.

Abril-Perez, Carlos; (...); Botella-Estrada, Rafael

Article. 10.1093/ced/llad171. 2023


Successful Treatment of Mogamulizumab-Associated Rash With Upadacitinib: Evidence From 2 Cases.

Martin-Torregrosa, Daniel; (...); Botella-Estrada, Rafael

Article. 10.1001/jamadermatol.2024.4582. 2024

  • Open Access.

Successful Treatment of Stimulator of Interferon Genes-Associated Vasculopathy of Infantile Onset SAVI Syndrome With Anifrolumab.

Mansilla-Polo M; (...); Botella-Estrada R

Article. 10.1001/jamadermatol.2024.2160. 2024


Switching from dupilumab to tralokinumab in patients with atopic dermatitis due to inefficacy or side effects.

Lasheras-Pérez MA; (...); Rodriguez-Serna M

Article. 10.1111/ijd.16926. 2024


Tattoo-Associated Common Wart

Mansilla-Polo, M., Llavador-Ros, M., Botella-Estrada, R.

Editorial Material. 10.1016/j.ad.2024.05.001. 2024

  • Open Access.

Tattoo-Associated Common Wart.

Mansilla-Polo, M, Llavador-Ros, M, Botella-Estrada, R

Article. 10.1016/j.ad.2023.04.037. 2023


Therapeutic approach in heart failure with poor diuretic response. Peripheral ultrafiltration vs. conventional treatment

Lopez-Vilella, R.; (...); Almenar Bonet, L.

Meeting Abstract. 2023


Therapeutic approach in heart failure with poor diuretic response: peripheral ultrafiltration vs. conventional treatment.

López-Vilella R; (...); Almenar Bonet L

Article. 10.1002/ehf2.14386. 2023

  • Open Access.

Toxic-metabolic encephalopathy induced by metronidazole and disulfiram: classics never die.

Chovi-Trull, Maria; (...); Poveda-Andres, Jose Luis

Article. 10.1136/ejhpharm-2024-004184. 2024


Treatment of palmoplantar psoriasis with oral roflumilast: a case series.

Lasheras-Perez, Miguel Antonio; (...); Botella-Estrada, Rafael

Article. 10.1093/ced/llae229. 2024


Use of an electrospun bioveil is safe and does not decrease skin graft take on burn wounds: A randomised, controlled clinical trial.

Perez-Del-Caz, Maria Dolores; (...); Perez-Plaza, Aranzazu

Article. 10.1016/j.burns.2025.107427. 2025


Usefulness of biomarkers to predict prognosis after heart transplant

Lopez-Vilella, Raquel; (...); Boneta, Luis Almenar

Article. 10.1016/j.rec.2024.04.019. 2024

  • Open Access.

Compartir el projecte